Ledger.Open graph →
SEC Form D · Amendment · filed May 28, 2015

Transplant Genomics Inc

Offering
$3.2M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Other
Location
BROOKLINE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Michael Abecassis · Brookline, MADirectorStanley Rose · Brookline, MAExec · DirectorFaouzi Sefrioui · Woodinville, WADirectorVernon W. Bryant, Jr · Fort Worth, TXExec · DirectorDaniel Solomon · San Rafael, CADirectorSaladin El Ayoubi · Seattle, WADirectorLisanne T. Davidson · Fort Worth, TXExec · DirectorDaniel Solomon · Brookline, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗